Navigation Links
Sinovac Reports Unaudited First Quarter 2011 Financial Results
Date:5/13/2011

able for 30 days.

About SinovacSinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases including hepatitis A, seasonal influenza, H5N1 (bird flu) pandemic influenza and H1N1 influenza. In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, PANFLU.1, and has received orders from the Chinese Central Government pursuit to the government stockpiling program. The Company is developing a number of new vaccine products, including vaccines for pneumococcal conjugate, enterovirus 71 (EV71) (against Hand, Foot & Mouth Disease), Japanese Encephalitis, animal and human rabies, HIB and epidemic meningitis, chickenpox, mumps and rubella. Its wholly owned subsidiary, Tangshan Yian, is focusing on the research, development, manufacturing and commercialization of animal vaccines and has completed the field trials for an independently developed inactivated animal rabies vaccine, which is anticipated to be launched in 2011.

Safe Harbor StatementThis announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Sinovac
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Sinovac Presents at Two Investor Conferences in May 2011
2. Sinovac Files Annual Report on Form 20-F
3. Sinovac Participates in UBS Greater China Healthcare Corporate Day
4. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
5. Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV)
6. Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range
7. Sinovacs Stock Exchange Listing Moves to NASDAQ Global Select Market
8. Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
9. Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
10. Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
11. Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)...  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... non-statutory stock options to purchase an aggregate of 67,700 ... The awards were made pursuant to the NASDAQ inducement ... employment compensation. The inducement grants were approved ... are being made as an inducement material to each ...
(Date:8/1/2014)... 2014  With monumental health reform coming into effect, ... language. Clinical efficacy is no longer the sole driver ... like PCORI are directing roughly $1 billion a year ... and environments, the federal healthcare ecosystem is changing, and ... outcomes and managed markets to the right people in ...
(Date:8/1/2014)... LAVAL, Quebec and NEW YORK ... Inc. (NYSE/TSX: VRX) and Pershing Square Capital Management, L.P. ... by Allergan, Inc. (NYSE: AGN ) in ... Pershing Square regarding the tender offer rules.  ... an attempt to interfere with shareholders, efforts to call ...
Breaking Medicine Technology:PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2Pharmaceuticals Learning the Language of the New Healthcare Landscape 2Pharmaceuticals Learning the Language of the New Healthcare Landscape 3Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 2Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 3Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 4Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 5Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 6
... 15 Dynatronics Corporation (Nasdaq: DYNT ) today announced ... from Nasdaq stating that the Company has not complied with ... , Nasdaq provides the Company an opportunity to appeal this ... authorized to grant up to 180 additional calendar days to ...
... Verathon Inc. is pleased to introduce the GlideScope(®) ... views in DVD clarity, enabling quick intubation. The ... and digital camera, offers integrated real-time recording as well ... This latest addition to the GlideScope(®) brand also provides ...
Cached Medicine Technology:Verathon Introduces the GlideScope(R) Cobalt Advanced Video Laryngoscope (AVL); New Digital Technology Facilitates Quick Intubations 2
(Date:8/1/2014)... August 02, 2014 The successful development ... stamping business of Guangdong FODAY Automobile Co.,LTD. As early ... company had already organized an excellent team to develop ... of detailed, in-depth technical plans. The company’s vice president ... in the direct involvement of the specific arrangement and ...
(Date:8/1/2014)... one of the most famous dress suppliers in the world, ... online. At the moment, all the brand new items ... to the company’s senior spokesman, the special offer will last ... is limited. Those who are thinking of buying cheap bridesmaid ... All its products are delicately made by top designers. ...
(Date:8/1/2014)... Cannabis use among young people has spiked, with ... used marijuana at least once and 17 percent admitting to ... Drugs, Say ‘Yes to Life,’ volunteers from the Church of ... with factual information about drugs, to help reverse this alarming ... to Drugs, Say ‘Yes’ to Life,” volunteers have distributed 40,000 ...
(Date:8/1/2014)... The Judicial Panel on Multidistrict Litigation ... therapy caused strokes, heart attacks, and other injuries in ... F. Kennelly as the transferee judge and ordered what ... federal court. , As one of his first organizing ... of attorneys who will move the litigation forward on ...
(Date:8/1/2014)... Diego School of Medicine report that dietary capsaicin ... activation of a receptor on cells lining the intestines ... risk of colorectal tumors. , The findings are published ... Journal of Clinical Investigation . , The receptor or ... neurons, where it acts as a sentinel for heat, ...
Breaking Medicine News(10 mins):Health News:FODAY Automobile Company Is Now Working On The C60F FODAY Project 2Health News:iFitDress.com: Top Bridesmaid Dresses For The Global Customers 2Health News:Addressing a Serious Issue Affecting German Teens 2Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2Health News:Pepper and halt: Spicy chemical may inhibit gut tumors 2
... over 100 NFL Legends Announced, TAMPA, Fla., ... (GGAF) today announced an unprecedented humanitarian,initiative to assist ... U.S. Military Special Operations personnel and their families,through ... partnership today and unveiled a Gridiron Greats Super ...
... Mickey,s accidental death (October 18th) Hunter has been,changing ... Outreach,Foundation as National Spokesperson., CHICAGO, Nov. 12 ... Epilepsy Outreach Foundation (AEOF),joins with Hunter Tylo of ... nationwide,campaign to raise awareness of Epilepsy and educate ...
... accuracy of their annual formulations for human influenza vaccines ... the time, especially for seniors. Perhaps in part because ... upcoming influenza strains, approximately 36,000 people die each year ... the case of hurricanes, early warning of the location ...
... Nov. 12 As the exclusive official,breaking news service ... PR Newswire is featuring profiles of the exhibiting,organizations. The ... Company : Linemaster Switch ... Web URL : ...
... to ... reduces errors and hospital costs, DAYTONA BEACH, ... medication error reduction and hospital pharmacy I.V.,room automation, recently ... IntelliFill i.v.(TM), by the Alegent Health System. The,largest not-for-profit, ...
... Increased use of computers to create predictive models ... organised by the European Science Foundation (ESF), which ... the field. Human disease research produces an enormous ... animal models, high throughput genetic screening of human ...
Cached Medicine News:Health News:Warriors Unite: Mike Ditka & the Gridiron Greats Form Partnership to Assist Retired NFL Players & U.S. Military Special Operations Personnel 2Health News:Warriors Unite: Mike Ditka & the Gridiron Greats Form Partnership to Assist Retired NFL Players & U.S. Military Special Operations Personnel 3Health News:November: National Epilepsy Awareness Month Actress Hunter Tylo Turns Tragic Loss Into Hope 2Health News:A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 2Health News:A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 3Health News:A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 4Health News:Linemaster Switch Corporation Exhibiting at MEDICA 2008 2Health News:Alegent Health System Automates I.V. Preparation to Enhance Patient Safety 2Health News:Computers make sense of experiments on human disease 2Health News:Computers make sense of experiments on human disease 3
... Proven tension-free sling technology ... porcine acellular collagen matrix sling, ... tissue-to-tissue contact between sling and ... urethral or vaginal abrasion or ...
... Delivers the advanced performance ... exceptional strength, versatility, and durability ... implant that augments the effectiveness ... pelvic floor reconstruction. Comprised of ...
... system is a state-of-the-art, comprehensive cardiac ... programs, modalities, and parameters are highly ... multiple applications including cardiac and pulmonary ... clinics. Its open architecture delivers flexibility ...
NephroMax High Pressure Nephrostomy Balloon Catheter allows one-step, atraumatic dilatation of the nephrostomy tract....
Medicine Products: